Breaking News: BIOA – Market Insights, Analysis & Latest Updates

BIOA

Wall Street analysts initiate coverage of BioAge Labs

BioAge Labs has caught Wall Street's attention, with analysts initiating coverage on its promising obesity treatment azelaprag, highlighting potential revenue and partnerships with major firms.

investing.com • 21/10/2024 - 14:43 PM

BIOA

BioAge Labs opens at $22.50, IPO priced at $18

Bioage Labs opened at $22.50, outperforming its IPO price of $18, indicating strong investor interest and confidence.

investing.com • 26/09/2024 - 16:27 PM

Greed and Fear Index

Note: The data is for reference only.

Greed

Wall Street analysts initiate coverage of BioAge Labs

BioAge Labs opens at $22.50, IPO priced at $18

Currency